SEPTInvestingStart Free
Stocks/XRAY/SEC Filings/8-K Nov 5, 2026

XRAY 8-K: Guidance cut

Dentsply Sirona

Filed with the SEC on Nov 5, 2026 · accession 0000818479-26-000285

XRAY filed a 8-K (current report) with the SEC on Nov 5, 2026. Dentsply Sirona reported Q3 2026 net sales of $836 million, down 7.6% year-over-year, with adjusted EPS of $0.29 versus $0.42 a year ago. The stock moved -5.3% by the first close after the filing.

Summary of the filing

Dentsply Sirona reported Q3 2026 net sales of $836 million, down 7.6% year-over-year, with adjusted EPS of $0.29 versus $0.42 a year ago. The company updated its FY2026 outlook to approximately $3.5 billion in net sales and adjusted EPS of $1.20 to $1.30, reflecting continued challenging industry conditions.

For details, click here →How to read a 8-K →

Key details

Q3 2026 net sales$836.0M
Q3 2025 net sales$904.0M
Q3 2026 adjusted EPS$0
Q3 2025 adjusted EPS$0
Q3 2026 GAAP diluted loss per share-$0
Q3 2026 adjusted EBITDA$146.0M
Q3 2026 operating cash flow$32.0M
Q3 2026 share repurchases$13.0M
Cash and cash equivalents as of September 30, 2026$195.0M
FY2026 net sales outlook$3.5B
IssuerDENTSPLY SIRONA Inc.
President and chief executive officerDan Scavilla

How XRAY stock reacted

Close before

$10.65

Nov 4, 2026

First close after

-5.26%

$10.09

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for XRAY, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for XRAY?

Click here

Frequently asked questions

What did XRAY file with the SEC on Nov 5, 2026?

XRAY filed a 8-K (Guidance cut). Dentsply Sirona reported Q3 2026 net sales of $836 million, down 7.6% year-over-year, with adjusted EPS of $0.29 versus $0.42 a year ago. The company updated its FY2026 outlook to approximately $3.5 billion in net sales and adjusted EPS of $1.20 to $1.30, reflecting continued challenging industry conditions.

What does a guidance cut mean for XRAY stock?

Guidance is the company’s own forecast. Investors price stocks on the future, so a raise or cut often moves the stock more than the past quarter’s numbers.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did XRAY stock react to this filing?

XRAY closed at $10.65 before the filing and $10.09 on Nov 5, 2026 (-5.26%).

Other XRAY SEC filings

  • 10-Q · SEC filingNov 5, 2026
  • 8-K · Material agreementOct 9, 2026
  • 8-K · SEC filingAug 7, 2026
  • 8-K · Guidance raiseAug 6, 2026
  • 10-Q · SEC filingAug 6, 2026
  • 8-K · Cfo changeJun 11, 2026
  • 8-K · SEC filingJun 4, 2026
  • 10-Q · SEC filingMay 5, 2026
  • 8-K · SEC filingMay 5, 2026
  • DEF 14A · Board changeApr 23, 2026

Get alerts when XRAY files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
XRAY overviewXRAY analysisXRAY newsLatest SEC filings
Source: SEC EDGAR filing 0000818479-26-000285. The summary and key details are extracted by SEPT from the filing and may contain errors. Price reaction uses daily closing prices. Not financial advice.